{
    "clinical_study": {
        "@rank": "117908", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Assess the efficacy of thioctic acid in treating a single patient with mitochondrial\n      myopathy."
        }, 
        "brief_title": "Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy", 
        "condition": "Mitochondrial Myopathy", 
        "condition_browse": {
            "mesh_term": [
                "Muscular Diseases", 
                "Mitochondrial Myopathies"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: The patient receives one thioctic acid tablet 3 times a day.  If patient\n      experiences no side effects after 1 week, 2 tablets are administered and given 3 times a day\n      over 3 months for compassionate use.\n\n      The patient is followed at weeks 3, 8, and 12."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n          -  Long standing ophthalmoparesis and fatiguable weakness of the limbs\n\n          -  Mild ataxia and no central nervous system involvement\n\n          -  History of mitochondrial DNA deletion and a measurable biochemical defect of the\n             respiratory chain\n\n          -  Steady deterioration in skeletal muscle mass and power over 5 years\n\n        --Prior/Concurrent Therapy--\n\n          -  Previous participation in studies of muscle disease natural history (CRC Protocol\n             183A)"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "1", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004770", 
            "org_study_id": "199/11774", 
            "secondary_id": "URMC-5231"
        }, 
        "intervention": {
            "intervention_name": "thioctic acid", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Thioctic Acid"
        }, 
        "keyword": [
            "inborn errors of metabolism", 
            "mitochondrial myopathy", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "University of Rochester", 
            "last_name": "Robert Griggs", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004770"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Rochester", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "October 1995", 
        "study_design": "Endpoint Classification: Efficacy Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2001"
    }, 
    "geocoordinates": {}
}